Skip navigation
Home
News
Products
about IR-World
Team
Customers
Partner
Contact
DE
EN
Communicators
are winners!
Text der Meldung
More News
03.08.2022
Medigene provides Q2 update and 6M report 2022
12.05.2022
Medigene AG: Dr. Selwyn Ho appointed new CEO of Medigene
04.05.2022
Medigene provides Q1 2022 update
25.04.2022
Medigene publication details augmentation of PRAME-specific TCR-4 by PD1-41BB switch receptor
13.04.2022
Medigene participates at upcoming conferences
21.02.2022
BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
03.02.2022
Medigene AG: Medigene reports preliminary efficacy and immune monitoring data of Phase I of Phase I/II MDG1011 trial in blood cancers
21.12.2021
Medigene achieves positive preliminary results in Phase I of Phase I/II trial of TCR-T therapy MDG1011 in blood cancers
08.12.2021
Medigene AG: New safety data shows Medigene's inducible system produces correctly-paired T cell receptors only
02.12.2021
Medigene AG: Medigene, IRICoR, and University of Montréal expand analyses of potentially novel cancer antigens
First
Previous
1
2
3
4
5
6
7
Next
Last